Collaborate with Living Technology

Partner with us to advance fungal microfluidics. We're looking for academic labs, pharma R&D groups, and grant collaborators for our initial beta cohort.

Four ways to partner

🧫

Beta Testing Program

Free Sivoro Start kits to qualified academic labs in exchange for structured feedback data and a co-authorship agreement on resulting publications.

  • No cost to academic PI
  • Structured usage report
  • Co-authorship on publications
  • Priority access to upgrades
🔬

Co-Development

Custom strain engineering partnerships. Work with Sivoro to build application-specific chassis variants for your research domain.

  • Application-specific strains
  • Shared IP negotiated upfront
  • Technical support throughout
  • Joint milestone planning
📄

Joint Publications

Shared authorship on methods papers, validation datasets, and application notes. Help us build the scientific literature around living microfluidics.

  • Shared first/co-authorship
  • Data sharing agreement
  • Pre-publication review
  • Open-access preferred
🏛️

SBIR Partnership

Collaborate on NSF/NIH SBIR/STTR grant applications. Academic co-investigators welcome — particularly in microfluidics, synthetic biology, and organ-on-chip.

  • NSF SBIR Phase I target
  • NIH STTR pathway open
  • Academic co-PI welcome
  • Indirect cost pass-through

Partnership Inquiry

Email us directly — we respond to all partnership inquiries within 2 business days.

Send your inquiry to:

partners@sivoro.bio

Include your institution, PI name, research area, and which collaboration model interests you. We'll respond with an MTA and next steps.

Beta TestingCo-DevelopmentJoint PublicationsSBIR Partnership
Send Partnership Inquiry →

Common Questions

Sivoro retains ownership of the underlying strain and scaffold IP. Any application-specific discoveries made by the partner lab using our platform belong to the partner institution. We ask for a right-of-first-negotiation on commercializing co-developed application IP.
Our standard Material Transfer Agreement covers use limitations (research only, BSL-1 containment), no redistribution, and reporting obligations. For co-development partnerships a separate sponsored research agreement is used. Legal review typically takes 2–4 weeks.
Yes — publication is encouraged. We ask for a 30-day pre-publication review period to check for inadvertent IP disclosure. Co-authorship is offered in exchange for substantial intellectual contribution; acknowledgment is sufficient for materials-only use.
Strains are shipped as glycerol stocks at −80°C with a certificate of analysis. Currently we distribute within the US only. International distribution pending export license review. Typical lead time is 3–4 weeks after MTA execution.